Easywell Biomedicals, Inc.

Easywell Biomedicals, Inc.verified

1799.TWO

Price:

$32.75

Market Cap:

$4.08B

Easywell Biomedicals, Inc. develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in the United States and Asia. It develops TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; and TLX-011 for treatment of inflammatory lesions of rosacea. The company also develops TWB-201 for Parkinson patch; TLX-501, an urinary medicine; and TLX-502, a pneumonia medicine, as well as provides medical devices. It has ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2007-12-31

Stock Exchange

TWO

Ticker

1799.TWO

The Current Ratio as of December 2025 (TTM) for Easywell Biomedicals, Inc. (1799.TWO) is 2.45

According to Easywell Biomedicals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.45. This represents a change of 3.84% compared to the average of 2.36 of the last 4 quarters.

Easywell Biomedicals, Inc. (1799.TWO) Historical Current Ratio (quarterly & annually)

How has 1799.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Easywell Biomedicals, Inc. over the last ten years is 5.46. The current 2.45 Current Ratio has changed 4.39% with respect to the historical average. Over the past ten years (40 quarters), 1799.TWO's Current Ratio was at its highest in in the March 2023 quarter at 5.19. The Current Ratio was at its lowest in in the December 2022 quarter at 0.

Quarterly (TTM)
Annual

Average

5.46

Median

5.14

Minimum

0

Maximum

14.10

Easywell Biomedicals, Inc. (1799.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Easywell Biomedicals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Current Ratio = 14.10

Minimum Annual Increase = -54.37%

Minimum Annual Current Ratio = 0

Quarterly (TTM)
Annual
YearCurrent RatioChange
20241.93-51.47%
20233.98-38.14%
20226.43-54.37%
202114.10123.84%
20206.30Infinity%

Easywell Biomedicals, Inc. (1799.TWO) Average Current Ratio

How has 1799.TWO Current Ratio performed in the past?

The current Current Ratio of Easywell Biomedicals, Inc. (1799.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.11

5-year avg

6.55

10-year avg

5.46

Easywell Biomedicals, Inc. (1799.TWO) Current Ratio vs. Peers

How is 1799.TWO’s Current Ratio compared to its peers?

Easywell Biomedicals, Inc.’s Current Ratio is greater than Orient EuroPharma Co., Ltd. (1.39), greater than Orient Pharma Co., Ltd. (1.76), less than BioGend Therapeutics Co., Ltd. (21.53), greater than Onyx Healthcare Inc. (1.86), greater than Bionime Corporation (0.80), less than AnnJi (4.99), less than Medigen Biotechnology Corp. (4.43), less than UnicoCell Biomed Co., Ltd. (35.10), less than Formosa Pharmaceuticals, Inc. (9.85), less than Mercury Biopharmaceutical Corporation (9.21),

Build a custom stock screener for Easywell Biomedicals, Inc. (1799.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Easywell Biomedicals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Easywell Biomedicals, Inc. (1799.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Easywell Biomedicals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Easywell Biomedicals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Easywell Biomedicals, Inc. (1799.TWO)?

What is the highest Current Ratio for Easywell Biomedicals, Inc. (1799.TWO)?

What is the 3-year average Current Ratio for Easywell Biomedicals, Inc. (1799.TWO)?

What is the 5-year average Current Ratio for Easywell Biomedicals, Inc. (1799.TWO)?

How does the current Current Ratio for Easywell Biomedicals, Inc. (1799.TWO) compare to its historical average?